LOGIN  |  REGISTER

Medpace (NASDAQ: MEDP) Stock Quote

Last Trade: US$400.24 -0.39 -0.10
Volume: 72,986
5-Day Change: -0.87%
YTD Change: 30.57%
Market Cap: US$12.400B

Latest News From Medpace

Revenue of $511.0 million in the first quarter of 2024 increased 17.7% from revenue of $434.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $615.6 million in the first quarter of 2024, representing an increase of 10.8% from net new business awards of $555.8 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of... Read More
CINCINNATI / Mar 28, 2024 / Business Wire / Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in... Read More
Revenue of $498.4 million in the fourth quarter of 2023 increased 26.5% from revenue of $394.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.5%. Net new business awards were $614.7 million in the fourth quarter of 2023, representing an increase of 26.7% from net new business awards of $485.1 million for the comparable prior-year period, which resulted in a net book-to-bill ratio... Read More
CINCINNATI / Jan 03, 2024 / Business Wire / Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2023 financial results after the market close on Monday, February 12, 2024. The Company will host a conference call the following morning, Tuesday, February 13, 2024, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested... Read More
Revenue of $492.5 million in the third quarter of 2023 increased 28.3% from revenue of $383.7 million for the comparable prior-year period, representing a backlog conversion rate of 19.1%. Net new business awards were $611.5 million in the third quarter of 2023, representing an increase of 29.9% from net new business awards of $470.9 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of... Read More
CINCINNATI / Sep 26, 2023 / Business Wire / Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2023 financial results after the market close on Monday, October 23, 2023. The Company will host a conference call the following morning, Tuesday, October 24, 2023, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register... Read More
Revenue of $460.9 million in the second quarter of 2023 increased 31.2% from revenue of $351.2 million for the comparable prior-year period, representing a backlog conversion rate of 18.7%. Net new business awards were $574.8 million in the second quarter of 2023, representing an increase of 27.6% from net new business awards of $450.6 million for the comparable prior-year period, which resulted in a net book-to-bill ratio... Read More
CINCINNATI / Jul 05, 2023 / Business Wire / Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2023 financial results after the market close on Monday, July 24, 2023. The Company will host a conference call the following morning, Tuesday, July 25, 2023, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in... Read More
Revenue of $434.1 million in the first quarter of 2023 increased 31.2% from revenue of $330.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.6%. Net new business awards were $555.8 million in the first quarter of 2023, representing an increase of 31.4% from net new business awards of $423.0 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of... Read More
CINCINNATI / Mar 28, 2023 / Business Wire / Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2023 financial results after the market close on Monday, April 24, 2023. The Company will host a conference call the following morning, Tuesday, April 25, 2023, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in... Read More
CINCINNATI / Feb 13, 2023 / Business Wire / Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Financial Results Revenue for the three months ended December 31, 2022 increased 27.7% to $394.1 million, compared to $308.6 million for the comparable prior-year period. On a constant currency organic basis, revenue... Read More
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2022 financial results after the market close on Monday, February 13, 2023. The Company will host a conference call the following morning, Tuesday, February 14, 2023, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on... Read More
Compass Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB